ECSP024257A - Proteinas antigenas del virus de la enfermedad de la mancha blanca en el camaron y usos de las mismas - Google Patents

Proteinas antigenas del virus de la enfermedad de la mancha blanca en el camaron y usos de las mismas

Info

Publication number
ECSP024257A
ECSP024257A EC2002004257A ECSP024257A ECSP024257A EC SP024257 A ECSP024257 A EC SP024257A EC 2002004257 A EC2002004257 A EC 2002004257A EC SP024257 A ECSP024257 A EC SP024257A EC SP024257 A ECSP024257 A EC SP024257A
Authority
EC
Ecuador
Prior art keywords
proteins
white spot
vaccines
disease
shrimp
Prior art date
Application number
EC2002004257A
Other languages
English (en)
Inventor
Hulten Maria Cornelia Wilhelmina Van
Justinus Maria Vlak
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ECSP024257A publication Critical patent/ECSP024257A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/18011—Nimaviridae
    • C12N2710/18022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/817—Viral vaccine for fish

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a proteínas antigénicas derivadas del virus de la enfermedad de la mancha blanca (WSSV - White Spot Syndrome Virus) que tienen un tamaño estimado de 19 kDa (VP19) ó kDa (VP13), al uso de estas proteínas en vacunas y a vacunas a base de estas proteínas. Además la invención se refiere a anticuerpos contra estas proteínas y al uso de anticuerpos en vacunas, a secuencias de ácido nucleico que codifican estas proteínas y a su uso en vacunas. La invención también se refiere al uso de dichas proteínas en la elaboración de una vacuna para la profilaxis y/o tratamiento de la enfermedad de la mancha blanca en crustáceos, a vacunas vectores y a Kits diagnóstico que comprende dichos ácidos nucleicos o anticuerpos.
EC2002004257A 2000-09-15 2002-05-15 Proteinas antigenas del virus de la enfermedad de la mancha blanca en el camaron y usos de las mismas ECSP024257A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00203186 2000-09-15

Publications (1)

Publication Number Publication Date
ECSP024257A true ECSP024257A (es) 2002-08-01

Family

ID=8172024

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2002004257A ECSP024257A (es) 2000-09-15 2002-05-15 Proteinas antigenas del virus de la enfermedad de la mancha blanca en el camaron y usos de las mismas

Country Status (10)

Country Link
US (1) US6908616B2 (es)
EP (1) EP1366169A2 (es)
JP (1) JP3780256B2 (es)
CN (2) CN1651458A (es)
AU (1) AU780206B2 (es)
CA (1) CA2391407A1 (es)
EC (1) ECSP024257A (es)
MX (1) MXPA02004861A (es)
SG (1) SG144692A1 (es)
WO (1) WO2002022664A2 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004041005A (ja) * 2002-07-08 2004-02-12 Gen Corp:Kk 抗ホワイトスポット病組成物
EP1545600A4 (en) * 2002-09-16 2006-07-12 Advanced Bionutrition Corp PROTEIN AND PEPTIDE EXPRESSION FOR PASSIVE IMMUNITY
KR100489617B1 (ko) * 2002-09-24 2005-05-17 주식회사 단바이오텍 흰반점바이러스 감염의 예방 및 치료를 위한 수용성 항체단백질 및 이를 포함한 알, 및 이들의 제조방법
JP5183064B2 (ja) * 2003-07-02 2013-04-17 エムユーエスシー ファウンデイション フォー リサーチ デべロップメント 甲殻類動物、及び他の無脊椎動物における、ｄｓＲＮＡで誘導された特異的、及び非特異的免疫、及びそこで使用する生物送達媒体
CN101023095B (zh) * 2004-07-09 2013-07-03 绿色生命实验室有限公司 基因工程蛋白质p40及其应用
KR100782332B1 (ko) * 2006-01-23 2007-12-06 주식회사 바이오리더스 새우 흰 반점 바이러스 항원의 표면 발현벡터 및 이에 의해형질전환된 미생물
CN1932520B (zh) * 2006-09-29 2012-03-21 武汉大学 检测对虾白斑综合症病毒的试纸条及其制备方法
CN101919873B (zh) * 2010-07-16 2011-05-04 韩健宝 抗wssv和/或tsv的核酸药物
US20120107355A1 (en) 2010-10-27 2012-05-03 Harrisvaccines, Inc. Method of rapidly producing improved vaccines for animals
US10004797B2 (en) 2010-10-27 2018-06-26 Harrisvaccines, Inc. Method of rapidly producing improved vaccines for animals
US8822427B2 (en) 2010-10-27 2014-09-02 Harrisvaccines Methods and compositions to protect aquatic invertebrates from disease
MY161995A (en) * 2010-11-10 2017-05-31 Univ Malaya Vaccine against white spot syndrome virus
MY153741A (en) 2010-11-10 2015-03-13 Univ Malaya A method for producing bio-active agent for the prevention of disease caused by white spot syndrome baculovirus complex and a bio-active agent derived thereof
CN102174518B (zh) * 2011-01-30 2012-12-19 中国农业科学院哈尔滨兽医研究所 虾白斑综合征病毒iel启动子主要顺式作用元件及与其结合的转录因子和应用
CN105247043A (zh) * 2013-05-31 2016-01-13 英特维特国际股份有限公司 鳞片脱落疾病(sdd)致病病毒及其衍生物
US20220119506A1 (en) * 2018-06-05 2022-04-21 Novobind Livestock Therapeutics Inc. Antibodies against aquaculture disease-causing agents and uses thereof
CN110013485B (zh) * 2019-03-07 2021-07-20 汕头大学 反义核酸AMO-miR-9875在制备抗白斑综合症病毒制剂中的应用
CN110438054A (zh) * 2019-07-26 2019-11-12 上海海洋大学 vp19转基因蓝藻及其在制备防治对虾白斑综合征病毒药物中的用途
KR102330545B1 (ko) * 2019-11-18 2021-11-29 (주)애드바이오텍 새우 폐사 방지용 난황항체의 제조방법
CN112094853A (zh) * 2020-09-24 2020-12-18 扬州大学 白斑综合征病毒vp28基因、重组蛋白、多克隆抗体及制备方法和应用
CN120775037B (zh) * 2025-08-28 2026-05-01 厦门昶科芯抗生物技术有限公司 一种抗对虾白斑综合征病毒vp19的纳米抗体及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834589A (en) * 1990-12-14 1998-11-10 New York University Chimeric viral receptor polypeptides
US5824535A (en) * 1996-01-17 1998-10-20 Kou; Guang-Hsiung Identification, purification and detection of WSBV (Baculovirus associated with white spot syndrome)
US5840535A (en) * 1997-06-02 1998-11-24 Incyte Pharmaceuticals, Inc. DNA encoding a zinc ring protein
JP4786093B2 (ja) * 1999-08-03 2011-10-05 インターベツト・インターナシヨナル・ベー・ベー 白点症候群ウイルス由来のタンパク質及びその使用
CN1303942A (zh) * 1999-11-24 2001-07-18 国家海洋局第三海洋研究所 对虾白斑杆状病毒基因组DNA序列及c DNA序列

Also Published As

Publication number Publication date
EP1366169A2 (en) 2003-12-03
CN1193094C (zh) 2005-03-16
JP2004508818A (ja) 2004-03-25
CN1651458A (zh) 2005-08-10
AU2055402A (en) 2002-03-26
SG144692A1 (en) 2008-08-28
MXPA02004861A (es) 2003-05-23
CA2391407A1 (en) 2002-03-21
US20040028700A1 (en) 2004-02-12
AU780206B2 (en) 2005-03-10
WO2002022664A2 (en) 2002-03-21
US6908616B2 (en) 2005-06-21
CN1437654A (zh) 2003-08-20
WO2002022664A3 (en) 2003-10-09
JP3780256B2 (ja) 2006-05-31

Similar Documents

Publication Publication Date Title
SG144692A1 (en) Antigenic proteins of shrimp white spot syndrome virus and uses thereof
ES2505695T3 (es) Composiciones inmunógenas para Streptococcus pyogenes
ECSP093601A (es) Proteínas derivadas del virus del síndrome de mancha blanca y sus usos
PT1090033E (pt) Particulas de proteinas de envelope do hcv: utilizacao para vacinacao
CY1115749T1 (el) Κυκλοϊος χοιρων, νουκλεϊνικα οξεα, πολυπεπτιδια και εμβολια
CY1107146T1 (el) Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad)
BRPI0208183B8 (pt) peptídeo antígeno de câncer modificado por wt1 e vacinas para câncer
ATE411043T1 (de) Verfahren von dna-impfung
BRPI0407877A (pt) conjugado de peptìdeo-proteìna, vacina para a prevenção ou melhora da infecção pelo vìrus influenza, e, método para induzir um resposta imune em um paciente
MX9202724A (es) Composicion que comprende un vector recombinante del agente lelystad y vacuna que comprende la misma.
JP2008508859A5 (es)
SI2280721T1 (en) Indoleamine 2, 3-dioxygenase based immunotherapy
EA200401405A1 (ru) Модифицированный осповакцинный вирус анкара для вакцинации новорожденных
EP4226938A3 (en) Coronavirus vaccine
ATE365749T1 (de) Humane peptide/proteine, die das töten von zellen,einschliesslich lymphoide tumorzellen, herbeiführen oder bewirken
MXPA02011545A (es) Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela.
MD20100029A (ro) Herpesvirus recombinant al crapului de koi (KHV) sau Cyprinid herpesvirus 3 (CyHV-3) si vaccin pentru prevenirea bolii cauzate de KHV/CyHV-3 la Cyprinus carpio carpio sau Cyprinus carpio koi
BR0316291A (pt) Vacina contra hcv, métodos de prevenção ou de tratamento de uma infecção por hcv em um mamìfero e de vacinação de um indivìduo, e, uso de uma vacina contra hcv
ATE517184T1 (de) Hcv ns3/4a kodierende nukleinsäure
ECSP066495A (es) Composiciones y metodos para inhibir la infección por virus de síndrome de punto blanco (wssv)
FR2828405B1 (fr) Vaccin anti-coronavirus
TW200509964A (en) VP1 of foot-and-mouth disease virus
DE602006014720D1 (de) Immunstimulatorische kombination zur vorbeugung und behandlung von hepatitis c
EA200301125A1 (ru) Вакцины, включающие в качестве адъюванта интерферон типа i, и связанные с этим способы
DE60126490D1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form